Merck Inc. reported on the second quarter of 2021 ending June 30th. The Company is primarily a human pharmaceutical manufacturer but with a significant Animal Health segment. Merck as a corporation earned $1,545 million on revenue of $11,402 million with an EPS of $0.61 in the second quarter of the current fiscal year. Comparable values for Q2 of fiscal 2020 were net earnings of $3,002 million on revenue of $9,353 million with and EPS of $1.19.
For the Animal Health segment, sales attained $1,472 million, an increase of 34 percent on Q2 of 2020. Animal Health sales comprised 55.7 percent livestock and 44.3 percent companion species during the most recent quarter.